Total Payments
$6,503
2020 Payments
$63.52
Companies
25
Transactions
190
Medicare Patients
540
Medicare Billing
$36,083
Payment Breakdown by Category
Travel$3,177 (48.9%)
Food & Beverage$3,155 (48.5%)
Education$170.84 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,177 | 13 | 48.9% |
| Food and Beverage | $3,155 | 158 | 48.5% |
| Education | $170.84 | 19 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $1,727 | 4 | $0 (2017) |
| Amgen Inc. | $1,624 | 35 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,166 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $428.62 | 13 | $0 (2019) |
| Novo Nordisk Inc | $298.49 | 21 | $0 (2020) |
| Amarin Pharma Inc. | $155.34 | 21 | $0 (2020) |
| PFIZER INC. | $154.15 | 19 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $126.69 | 11 | $0 (2019) |
| Lilly USA, LLC | $101.01 | 4 | $0 (2019) |
| Allergan, Inc. | $97.00 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $63.52 | 4 | Allergan, Inc. ($38.24) |
| 2019 | $935.10 | 64 | AstraZeneca Pharmaceuticals LP ($310.00) |
| 2018 | $1,028 | 76 | Amgen Inc. ($176.20) |
| 2017 | $4,476 | 46 | Novo Nordisk AS ($1,727) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Diabetes | ||||||
| 01/30/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular | ||||||
| 01/22/2020 | Allergan, Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/26/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/09/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/04/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Neuroscience | ||||||
| 12/02/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: UROLOGY | ||||||
| 11/27/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/26/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/25/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
| 11/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: Diabetes | ||||||
| 11/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2019 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/31/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 10/18/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/14/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: VACCINES | ||||||
| 10/10/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 90 | 108 | $19,356 | $5,675 |
| 2020 | 8 | 450 | 575 | $91,201 | $30,408 |
Total Patients
540
Total Services
683
Medicare Billing
$36,083
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 64 | $13,248 | $4,091 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 21 | $3,003 | $839.98 | 28.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 23 | $3,105 | $744.73 | 24.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 234 | 325 | $63,480 | $19,191 | 30.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 58 | 78 | $10,530 | $4,370 | 41.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 54 | $7,402 | $2,213 | 29.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 26 | 26 | $2,964 | $1,585 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $3,019 | $1,412 | 46.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 44 | 44 | $1,800 | $704.04 | 39.1% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $780.00 | $700.08 | 89.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 23 | $1,226 | $232.47 | 19.0% |
About Dr. Mark Graves, MD
Dr. Mark Graves, MD is a Internal Medicine healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285702308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Graves, MD has received a total of $6,503 in payments from pharmaceutical and medical device companies, with $63.52 received in 2020. These payments were reported across 190 transactions from 25 companies. The most common payment nature is "Travel and Lodging" ($3,177).
As a Medicare-enrolled provider, Graves has provided services to 540 Medicare beneficiaries, totaling 683 services with total Medicare billing of $36,083. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Springfield, IL
- Active Since 11/30/2006
- Last Updated 12/10/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285702308
Products in Payments
- Tresiba (Drug) $1,768
- Repatha (Biological) $1,338
- FARXIGA (Drug) $223.19
- Prolia (Biological) $208.46
- Vascepa (Drug) $155.34
- Ozempic (Drug) $141.87
- LYRICA (Drug) $100.10
- SYMBICORT (Drug) $94.97
- Saxenda (Drug) $90.23
- XIFAXAN (Drug) $76.78
- LINZESS (Drug) $64.23
- Trintellix (Drug) $59.07
- Aimovig (Biological) $57.71
- Livalo (Drug) $51.75
- TOUJEO (Drug) $47.63
- STIOLTO RESPIMAT (Drug) $46.68
- JARDIANCE (Drug) $45.95
- JANUVIA (Drug) $39.07
- VRAYLAR (Drug) $35.66
- PREVNAR - 13 (Biological) $30.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Internal Medicine $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
Internal Medicine $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Internal Medicine $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Internal Medicine $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Internal Medicine $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372
Internal Medicine $47,372